Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.

CY, Wu; YJ, Chen; HJ, Ho; YC, Hsu; KN, Kuo; MS, Wu; JT, Lin

doi:10.1001/2012.jama.11975

Public

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.

Shared by NobleBlocks on Nov 1, 2012 • 12:00 AM UTC

Authors:

Wu CY

Chen YJ

Ho HJ

Abstract

Context Tumor recurrence is a major issue for patients with hepatocellular carcinoma (HCC) following curative liver resection.Objective To investigate the association between nucleoside analogue use and risk of tumor recurrence in patients with hepatitis B virus (HBV)--related HCC after curative sur...

Discussions